The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Formulations For Small Intestinal Delivery Of Rsv And Norovirus Antigens - EP3307239

The patent EP3307239 was granted to Vaxart on Sep 16, 2020. The application was originally filed on Jun 8, 2016 under application number EP16808196A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3307239

VAXART
Application Number
EP16808196A
Filing Date
Jun 8, 2016
Status
Granted And Under Opposition
Aug 14, 2020
Publication Date
Sep 16, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

IOSBIOJun 15, 2021LEONARDADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2010111989
INTERNATIONAL-SEARCH-REPORTUS2010111989
INTERNATIONAL-SEARCH-REPORTUS2015071994
OPPOSITIONUS2010111989
OPPOSITIONUS2013171185
OPPOSITIONWO2013148258
OPPOSITIONWO2016200951
SEARCHWO2011026111
SEARCHWO2013148258

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents